Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials - Quiz - MDSpire

Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials

  • By

  • Maria Esposito

  • Juan Manuel Morón-Ocaña

  • Aditya K. Gupta

  • Jordi Galván

  • Ayoub Bentohami

  • Frank Freischläger

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials

  • by Maria Esposito, Juan Manuel Morón-Ocaña, Aditya K. Gupta, Jordi Galván, Ayoub Bentohami, Frank Freischläger

  • July 1, 2026

Related Content

Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics

Correction: Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study